healthcare768

[healthcare768]

Hypertension in CKD Market-Size,Share,Outlook,and Opportunity Analysis,2020–2027

Chronic kidney disease (CKD) is the gradual loss of kidney function over a period of several years. Due to kidney failure, the organ’s function is severely impaired, which leads to accumulation of dangerous levels of waste and fluid in the body. Early detection can help prevent the progression of kidney to kidney failure. The treatment for CKD is aimed at stopping or slowing down the progression of the disease. Diuretics, RAS Blockade, β – Blockers, Calcium Channel Blockers etc. are some of the major drug used for the treatment of chronic kidney disease or its underlying cause. Global Hypertension in CKD Market - Impact of the Coronavirus (COVID-19) Pandemic Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it as a public health emergency. As the COVID-19 cases are surging, the risk for patients acquiring chronic kidney disease is also increasing. For instance, according to a study conducted in May 2020, by the researchers at Mount Sinai Health System, New York City, U.S., occurrence of kidney disease might increase as a post-COVID-19 effect in most of the COVID-19 positive patients. Moreover, according to the National Kidney Foundation, a study found that COVID-19 positive patients hospitalized in the span of March 11 and April 26, 2020, were likely to develop acute kidney injury (AKI) twice non-COVID patients. Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/4431 Market players are engaged in inorganic activities such as collaboration, in order to conduct research and development activities for various types of diseases, by combining their expertise and investment, which is expected to drive the growth of the global hypertension in CKD market Key players are indulged in collaboration, in order to conduct clinical trials for different diseases. For instance, in 2019, Boehringer Ingelheim collaborated with Eli Lilly and Company, in order to develop and commercialize Jardiance (empagliflozin), for the treatment of type 2 diabetes, heart failure, and chronic kidney disease. Currently, the companies, jointly, are conducting clinical trials to evaluate the safety and efficacy of Jardiance in people suffering from heart failure or chronic kidney disease, including in people with and without type 2 diabetes. Increasing product launches by key players is expected to drive growth of the market over the forecast period. For instance, in 2018, Kissei Pharmaceutical Co., Ltd. launched P-TOL Granules (Sucroferric oxyhydroxide) 250 mg and 500 mg, in Japan for the treatment of hyperphosphatemia, in patients suffering from chronic kidney disease. According to the National Center for Biotechnology Information: 2018, hyperphosphatemia in dialysis patients is associated with vascular wall stiffness, which leads to hypertension. Global Hypertension in CKD Market – Restraints Lack of awareness about chronic kidney disease is the major factor that is expected to restrain growth of the global hypertension in CKD market over the forecast period. Despite the attempts made by governments in order to increase awareness among the population about chronic kidney disease (CKD) through different ways: such as dissemination of clinical practice guidelines and recommendations for patients with CKD or its risk factors, community awareness on events such as World Kidney Day, and free screening for high-risk individuals such as Kidney Early Evaluation Program (KEEP), it has been found that the awareness of CKD among the population remains unacceptably low. Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/4431 Global Hypertension in CKD Market – Regional Analysis On the basis of region, the global hypertension in CKD market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold dominant position in the global hypertension in CKD market, owing to the

reimbursement policy for chronic kidney diseases in the region. For instance, on September 18, 2020, Centers for Medicare & Medicaid Services (CMS), a federal agency within the United States Department of Health and Human Services, announced the new Medicare model for the end-stage renal disease (ESRD), which is also called as the last stage of the chronic kidney disease. The model is End-Stage Renal Disease (ESRD) Treatment Choices (ETC) Model. The model encourages increased use of home dialysis and kidney transplants to help improve the quality of life of Medicare beneficiaries with ESRD. Moreover, this model will be implemented on January 1, 2021 and it is estimated that due to implementation of the model, US$ 23 million will be saved over a period of five and a half years. Global Hypertension in CKD Market – Competitive Landscape Major players operating in the global hypertension in CKD market include Sanofi S.A, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, AstraZeneca Plc, Novartis International AG, C.H. Boehringer Sohn AG & Ko. KG, Kissei Pharmaceutical Co., Ltd., Reata Pharmaceuticals, Inc., Ardelyx, and KBP Biosciences Holdings Limited. About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[healthcare768]

Telerehabilitation Services Market-Size,Share,Outlook,and Opportunity Analysis,2020–2027

Telerehabilitation is the delivery of rehabilitation services over telecommunication networks and the internet. The medical service uses the application of telecommunication to provide medical support via telecom or digital media, intervention and assessment to individuals with specific disorder. Telerehabilitation provides a diversity of clinical applications including the facility of assistive technology, teleconsultation by psychiatrist, remote therapy using tools, and others. Telerehabilitation services are needed for assessment, monitoring, consultations, diagnosis, and to manage therapies or to propose interactive therapies or therapeutic settings. Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/4438 Launches and approval of novel virtual rehabilitation and telerehabilitation solutions are expected to drive the market growth during the forecast period. Key players in the market are involved in developing novel rehabilitation solutions is expected to drive the market growth during the forecast period. For instance, In June 2016, Flexpoint Sensor Systems, Inc. launched 'Gloreha Sinfonia', an advanced, next generation medical rehabilitation technology. It includes Gloreha Hand Rehabilitation Glove, Sinfonia, DAS – Dynamic Arm Support, Workstation, and the innovative Virtual Reality Rehabilitation and customized, Therapy Management software. Development of novel systems for providing rehabilitation services are expected to drive the market growth during the forecast period. Development of novel systems for providing rehabilitation services is expected to drive the market growth during the forecast period. For instance, in July 2019, PT Genie, a digital health company, introduced PT Genie, a wearable device that keeps patients connected with their physical therapist remotely. PT Genie provides real-time feedback and an ongoing connection between patient and therapist to ensure that the exercise protocol is helping the patient recover. Global Telerehabilitation Services Market – Impact of Coronavirus (COVID-19) Pandemic The rapid global spread of COVID-19 is challenging healthcare systems worldwide in terms of healthcare planning, infrastructure, and finances. Healthcare professionals are forced to treat severely ill patients with limited access to ventilation equipment, qualified intensive care personnel or protective patient monitoring devices. Since December 2019, the novel coronavirus spread throughout China and across the world, causing a continuous increase in confirmed cases within a short period of time. The disease has spread to more than 200 countries across the globe with the World Health Organization declaring it as a public health emergency. For instance, according to the WHO Coronavirus (COVID-19) dashboard, the manifestation of the coronavirus disease has resulted in more than 143 million infected individuals worldwide as of April 21st 2021. The COVID 19 pandemic and lockdowns in various countries across the globe has impacted the financial status of businesses across all sectors Global Telerehabilitation Services Market: Restraint The major factors that hinder growth of the global telerehabilitation services market include limited awareness and lack of skilled professionals. Rural areas belonging to emerging economies such as Africa and Asia Pacific has very low awareness about such novel technologies, which is expected to be a major reason leading to slow adoption of virtual rehabilitation and telerehabilitation systems in such regions, thereby hindering the market growth. Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/4438 Key Players Major players operating in the global telerehabilitation services market are MTI America, UnaliWear Inc., Virtual Physical Therapists, Conversa Health, Rehab Management Pty Ltd, MindStreet Inc., MedRisk, NeoRehab, Global Outreach TeleRehabilitation Services, Inc., and Empatha About Coherent Market Insights Coherent Market Insights is a prominent

market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[healthcare768]

Polymerase Chain Reaction Market, by Product Type, by End User-Global Industry Insights, and Forecast to 2025

Polymerase Chain Reaction Market – Insights

Polymerase chain reaction (PCR) is extensively used for DNA amplification technique. It generates thousands to millions of copies of a particular DNA sequence. The PCR industry is shifting its focus away from macro-scale systems and is focused on developing the micro-scale devices. Micro-scale devices offer various benefits such as micro-scale sample sizes requires less blood from patients, it takes less reaction time and also offers cost-effective benefits, as many microfluidic devices are manufactured from inexpensive polymers. Increasing adoption of polymerase chain reaction in various diagnostic and research application, growing research and development funding in gene therapy, and continuous technological advancement in polymerase chain reaction are projected to augment growth of the market over the forecast period.

Get PDF Brochure Of This Research Report @

https://www.coherentmarketinsights.com/insight/request-pdf/1546

Increasing Numbers of Product Launches and Collaborations in Polymerase Chain Reaction are expected to Drive Growth of the Polymerase Chain Reaction Market

Key players in the polymerase chain reaction market are engaged in launching advanced and novel PCR instruments and consumables, which will allows rapid and easy nucleic acid amplification. For instance, in October 2017, Diatech Pharmacogenetics srl launched easyPGX: a ready to use in-vitro diagnostic real-time PCR product line and Helix: a polymerase chain reaction kit for the extraction of circulating free DNA from plasma. In September 2015, Bio-Rad Laboratories launched droplet digital PCR (ddPCR) Supermix for Residual DNA Quantification. The new supermix designed to use with Bio-Rad’s Droplet Digital PCR Systems offers highly precise and sensitive method for DNA measurement. In November 2014, Chai Biotechnologies Inc. introduced Open qPCR: Real-Time PCR Thermocycler. The new instrument is designed to use for genetic genotyping, pathogen detection, and relative DNA quantification. Moreover, in April 2014, Bio-Rad Laboratories launched Precision Blue Real-Time PCR Dye. The new Precision Blue dye is compatible with Bio-Rad’s universal qPCR supermixes, and can be used with all Bio-Rad’s CFx real time PCR systems.

Furthermore, key players are involved in several collaborations to expand their geographical horizon and increase patient reach. For instance, in March 2018, Akonni Biosystems Inc. and a Chinese in-vitro diagnostics company: Righton signed a commercial agreement, which enables Righton to sell Akonni's TruDiagnosis and TruTip Nucleic Acid Purification Kits in China. TruDiagnosis is based on proprietary on-slide PCR and gel-drop microarray technology. In January 2018, Thermo Fisher Scientific and Illumina, Inc. signed a commercial agreement. Under the agreement, Thermo Fisher will provide Ion AmpliSeq technology to Illumina for research purpose. Moreover, in December 2017, Genome Diagnostics (GenDx) signed a global reseller agreement with Thermo Fisher Scientific, assigning GenDx as a non-exclusive reseller of Thermo Fisher’s QuantStudio real-time PCR instrument. Under the agreement, GenDx will market the QuantStudio real-time PCR in the Netherlands and other European countries. Thus, significant organic and inorganic growth strategies by various key players is driving growth of the polymerase chain reaction market.

Increasing Prevalence of Chronic and Infectious Disease are Driving Growth of Polymerase Chain Reaction Market

Polymerase chain reaction is increasingly used in clinical diagnosis of infectious disease, nucleic acid amplification, paternity testing, DNA fingerprinting, detection and diagnosis of infectious disease, quality control, and personalized medicine. For instance, according to the Centers for Disease Control and Prevention (CDC), around 5,251 deaths due to the influenza infection were registered in 2015, in U.S. According to the World Health Organization (WHO), in 2015, around 32,000 estimated deaths were reported from tuberculosis and around 3, 23,000 new cases of TB cases were registered in the European region. According to the National Ambulatory Medical Care Survey: 2015 data findings, 16.8 million visits to physician offices for infectious and parasitic diseases were registered in the U.S. According to the World Health Organization (WHO), 2016, around 555,318 new cases of cancer were reported in 2012, in the Middle East Region. The region is expected to witness the highest relative increase of cancer cases among the regions in the world accounting to 961,098 cases by 2030. Moreover, according to the Cancer Atlas, 2012, about 1.1 million new cancer cases and 600,000 cancer deaths occurred annually in Latin America and the Caribbean, where lung cancer is the leading cause of cancer death for both genders combined in the region.

Request Sample Copy of Research Report @

https://www.coherentmarketinsights.com/insight/request-sample/1546 Key players operating in polymerase chain reaction market include F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., bioMérieux, S.A., Enzo Life Science, Inc., Abbott Laboratories, Takara Bio Inc., Becton, Dickinson and Company, and Danaher Corporation.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[healthcare768]

Clostridium Difficile Diagnostics and Treatment Market - by Product Type,By Diagnostic Test,By Distribution Channel,and Region-Global Industry Insights, and Forecast till 2025

Clostridium Difficile Diagnostics and Treatment Market – Insights

Clostridium difficile is a disease caused by bacteria. Symptoms of the disease includes diarrhea, nausea, colon inflammation, and others. Clostridium difficile infection affects older adults, and according to Centers for Disease Control and Prevention (CDC), 2015, clostridium difficile infection is the most common healthcare-associated infection. Furthermore, frequent use of antibiotic medication is also responsible for clostridium difficile infection, as antibiotics kill normal flora (good bacteria) and allow for multiplication of C. difficile bacteria. Common symptoms of clostridium difficile infection include watery diarrhea, dehydration, fever, nausea, loss of appetite, and weight loss. Life threatening symptoms of the disease includes abdominal distension, severe abdominal pain, and profuse diarrhea. Clostridium difficile infection management includes diagnosis of the infection using various tests and medication therapies using antibiotics such as Vancomycin and Fidaxomicin.

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1499

Rising prevalence of clostridium difficile infection is expected to boost growth of the market over the forecast period

Incidence of clostridium difficile infection has been witnessing an increase in the recent past, due to clostridium difficile infection recurrence and antibiotic resistance. According to Centers for Disease Control and Prevention (CDC), 2015, around half a million people in the U.S. suffer from clostridium difficile infection in a year. Moreover, according to National Center for Biotechnology Information (NCBI), an estimated 37,900 patients were suffering from clostridium difficile infection in Canada in 2012. A review and meta-analysis of studies published in National Center for Biotechnology Information (NCBI), 2016, conducted in China between 2010 and 2016 showed significant incidence of clostridium difficile infection in China. FThe global clostridium difficile diagnostics and treatment market was valued at US$ 1,272.2 million in 2016 and is expected to witness a robust CAGR of 8.2% over the forecast period (2017–2025).

Robust pipeline of various therapies is expected to boost growth of the clostridium difficile treatment market over the forecast period

Standard antibiotic drugs such as metronidazole, Vancomycin, and Fidaxomicin have been used for the treatment of clostridium difficile infection (CDI) since the recent past. Currently, there is no alternative therapies apart from antibiotics available for the treatment of clostridium difficile infection and only option available is surgery (in severe cases), fecal microbiota transplant, and probiotics in case of recurrent clostridium difficile infection. However, Manufacturers such as Rebiotix, Inc., Synthetic Biologics, Inc., Da Volterra, Crestovo LLC, and Immuron Ltd. have various microbiome therapeutics (new class of drugs) in pipeline for clostridium difficile infection indication. Rebiotix, Inc. has RBX7455 capsule in Phase 1 clinical trials, Synthetic Biologics Inc. has SYN-004 (ribaxamase) in Phase 2 clinical trials, and Da Volterra has DAV132 in clinical trials for antibiotic induced clostridium difficile infection. If these drugs show success in clinical trials, it could provide an alternative therapy for conventional antibiotics for treatment of the disease. Furthermore, probiotics are also gaining traction as they allow growth of natural flora through restoring natural balance of bacteria in the gut.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1499

However, low awareness about clostridium difficile infection symptoms and associated effects is expected to restrain the growth of the clostridium difficile diagnostics and treatment market over the forecast period.

Some major players operating in the clostridium difficile diagnostics and treatment market include Roche AG, Thermo Fisher Scientific Inc., Merck & Co., Pfizer, Inc., Actelion Pharmaceuticals, Alere, Inc., Trinity Biotech, Summit Therapeutics, Baxter International Inc., Sanofi S.A., Novartis AG, and AstraZeneca Plc.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[healthcare768]

Computer Assisted Surgical Systems Market-By Product Type,By Surgery Type,By End Users,and By Region-Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

Computer assisted surgical systems are used for pre-operative planning, surgical navigation, and to assist surgery procedure. Computer assisted surgeries commonly uses surgical robots that mimics human arm and carry out surgical procedures by series of small incisions. The advantages of using computer assisted surgical systems include improved access, magnified vision, and stabilized implantation via smart instrumentation assisted by infra-red camera for navigation and software. The demand for computer assisted surgery is growing at a fast pace due to precision, miniaturization, less pain, and less healing time as compared to conventional surgical practices. Moreover, technological advancements in surgical robots is also boosting growth of computer assisted surgical systems market. The high cost and maintenance of system, and lack of skilled professionals are expected to hinder growth of computer assisted surgical systems market.

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1487

Computer assisted surgical systems market Taxonomy:

By Product Type

Surgical Navigation Systems Surgical Robots Surgical Planners & Stimulators By Surgery Type

Gynecology Surgery General Surgery Urology Surgery Cardiovascular Surgery Neurosurgery Orthopedic Surgery Other Surgeries By End Users

Hospitals Ambulatory Surgical Centers Emergency Clinics Computer Assisted Surgical Systems Market Driver

Computer assisted surgeries are carried out with the help of surgical robotic arms, which facilitates the surgery via small incision and less tissue damage. Furthermore, accuracy and precision of computer assisted surgeries drive growth of computer assisted surgical systems market. Moreover, minimally invasive surgery lowers the cost of healthcare. For instance, the research studies conducted by Johns Hopkins suggests that minimally invasive procedures adopted by American hospitals saves around US$ 280 million to US$ 340 million per year spend for post-surgical complications occurred due to open surgery for appendix, colon, and lungs. According to the Health Research Funding report, around 400,000 robotic surgeries were performed in the U.S. in 2012 and had estimated around 25% increase in the rate of robotic surgery annually. Therefore, increasing use of surgical robots is expected to drive growth of computer assisted surgical systems market.

Computer assisted surgery is preferred over conventional surgical methods due to its advantages and advancements in technology. The focus of manufacturers of computer assisted surgical systems on upgrading the robotic instruments and its accessories with features like high resolution, precision, and flexibility of robotic device is expected to propel growth of computer assisted surgical systems market. Moreover, manufacturers are focusing on widening the applications of computer assisted surgical systems with the increasing advancements in surgical robotic systems. For instance, in 2018, Auris Surgical Robots, cleared FDA approval for Monarch, an Auris robotic endoscopy system, which can be used for diagnosing and treating lung cancer. Furthermore, the adoption of strategies such as merger and acquisition by manufacturers leads to the expansion of the market. For instance, in 2016, Zimmer Biomet acquired Medtech SA to enter the surgical robotics market.

Computer Assisted Surgical Systems Market Outlook

On the basis of region, computer assisted surgical systems market is segmented into North America, Latin America, Europe, Middle East, and Asia Pacific. North America accounts for dominant share in the global computer assisted surgical systems market, which is attributed by the technological advancements in the region, whereas Asia Pacific is expected to witness faster growth in computer assisted surgical system market over the forecast period due to increasing healthcare facilities and high rate of medical tourism in this region.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1487 Computer Assisted Surgical Systems Market - Key Players

The major players of computer assisted surgical systems market include Intuitive surgical, Inc., Stryker Corporation, Mazor Robotics Ltd., Hansen Medical, Inc. (a subsidiary of Auris Surgical Robotics), Accuray Incorporated, Omnicell, Inc., Smith & nephew, and Zimmer Biomet.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[healthcare768]

Insulin Delivery Devices Market,by Product Type,by Distribution Channel,and by Geography-Global Trends,and Forecast to 2025

Insulin Delivery Devices Market - Insights

Insulin is vital for people suffering from type 1 diabetes and type 2 diabetes. Preciously, patients with diabetes had to inject insulin using large glass syringes and reusable needles, both of which needed sterilization by boiling after each use. Improvements and innovations has led to development of insulin delivery devices such as pens and insulin pumps. Furthermore, insulin analogs have become available that enable both continuous subcutaneous insulin infusion (CSII) using an insulin pump and insulin therapy using multiple daily injections (MDI) to more closely match physiologic insulin patterns. Type or dosage of insulin can be changed, to meet the individual needs of the patient. Insulin can be packaged in vials (bottles), cartridges or prefilled pens. The cartridges are used with pen injectors whereas the vials are used with syringes.

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1352

Increasing prevalence of diabetes is expected to drive growth of the global insulin delivery devices market over the forecast period

Increasing prevalence and incidence of diabetes is a major factor driving the global insulin delivery devices market growth. According to the Centers for Disease Control and Prevention (CDC), 2014, around 29.1 million people in the U.S. have diabetes with a healthcare burden of around US$ 245 Bn and with an estimated 4.6–9.2% of pregnant women affected by gestational diabetes. Moreover, the Australian government launched National Diabetes Strategy (2016–2020), to prevent diabetes and support people living with diabetes. Thus, increasing government initiatives to support diabetic patients is expected to favor growth of the global insulin delivery devices market.

Development of systems and devices for improved drug delivery is expected to drive growth of the market. When compared with vial and syringe regimens, insulin pens offer a greater clinical efficacy, improved quality of life, and increased dosing accuracy, particularly at low doses. Thus, introduction of insulin pen devices has aided patients with diabetes mellitus in easier and more convenient treatment regimens. For instance, in January 2014, Novo Nordisk launched the NovoPen Echo in the U.S. market. This is the first and only pen device available in the U.S. with half-unit dosing and a memory function that can record the dose and time passed since the last injection.

Increasing adoption of advanced devices for insulin delivery is driving growth of the market

Increasing awareness among population regarding insulin delivery devices coupled with high demand for insulin administration for diabetes control are expected to drive growth of the market. Among regions, in 2017, North America, accounted for largest share in global insulin delivery devices market, followed by Europe, owing to high prevalence of lifestyle associated diseases, implementation of awareness programs regarding diabetes, and high adoption of advanced medical devices. For instance, in 2010, according to Journal of Diabetes Science and Technology, majorly insulin pumps were used on the American side of the Atlantic than on the European side, which is projected to propel demand for insulin pumps over the forecast period.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1352

Key players in the market are focusing on developing next generation devices to remain competitive, while seeking ways to enhance their design capabilities. For instance, in October 2017, Eli Lilly and Company announced its plans to invest US$ 72 million in an insulin manufacturing project at one of its Indianapolis, U.S. facilities. The investment will be used to replace an existing insulin vial filling line and allow the company to meet growing demand for its insulin - including Humalog (insulin lispro) and Humulin (human insulin) - while upgrading to state-of-the-art technology and preparing for its insulin pipeline.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[healthcare768]

Non-vascular Stents Market,by Product Type and by Region-Global Trends,and Forecast to 2025

Non-vascular Stents Market – Minimally Invasive Management of a Wide Variety of Circulatory Disorders

Non-vascular stents are a family of devices used for a variety of applications, including esophageal, biliary, colonic, tracheal, and bronchial implantations. Non-vascular stents employs minimally-invasive procedure for implantation. A minimally-invasive procedure offers faster recovery with reduced pain, and shorter hospital stay. Non-vascular stents are increasingly being used in various applications such as in the treatment of pulmonary, urological, and gastrointestinal diseases. The use of these stents is also increasing in the neural and ophthalmic fields.

The global non-vascular stents market was valued at US$ 934.7 million in 2017 and is expected to witness a robust CAGR of 4.7% over the forecast period (2017 - 2025).

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1340

Increasing demand for minimally invasive procedures is expected to boost market growth

Increasing demand for minimally invasive procedures is expected to be a major factor driving the growth of the global non-vascular stents market. Non-vascular stents involve small accurate incisions, resulting in relatively smaller and lesser noticeable scars incurred by conventional surgical procedures that compromise on patient safety. Such a procedure is associated with faster recovery time, thus reducing a patient’s hospital stay. Furthermore, reduced hospital stay in turn, is expected to lower the risk of contracting hospital-acquired infections such as bloodstream infection, urinary tract infection, etc. among patients. These factors pose as major drivers boosting growth of the non-vascular stents market.

Increasing prevalence of chronic diseases is expected to drive market growth

Increasing prevalence of gastrointestinal, urological and pulmonary or airway diseases is expected to fuel the demand for non-vascular stents. Conditions such as chronic obstructive pulmonary disease (COPD), central airway obstruction, and asthma demand the use of pulmonary stents, to open up narrowed airways and ease the respiration process. According to WHO, more than three million people die each year from COPDs worldwide and 90% of these deaths in low and middle income countries. Furthermore, in U.S., every year, kidney disorders kills more people than prostate or breast cancer. For instance, in 2013, approximately 47,000 Americans died from kidney disease. Gastrointestinal diseases have been a major problem and cover a wide variety of parts of the system, (i.e. rectum, intestines, duodenum, and esophagus). Generally, these diseases are treated with palliation with the use of non-vascular stents. In recent years, non-vascular stents have been a standard treatment for removing occluding tumors in the gastrointestinal system.

Advancements in technology to accelerate the market growth

Increasing advancements in technology and material is aiding in the development of specially designed stents for used in various indications, is increasing the demand for non-vascular stents in a wide range of applications. For instance, the development of biodegradable polymers and bio-absorbable scaffolds is increasing the use of stents in pulmonary, gastrointestinal, urological, and biliary strictures. Poly capro-lactone, poly acryl amine, and poly lactic acid-glycolic acid are few of the newly designed biodegradable stent materials, which eliminate the need for stent removal. Nitinol is increasingly being utilized in non-vascular self-expandable stents, as it offers super elasticity and therefore is beneficial to the stent placement in difficult segments of an internal tract. However, high costs of non-vascular stents is expected to negatively impact growth of the market.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1340

Major players operating in the global non-vascular stents market include Allium Medical, Boston Scientific, C.R. Bard, ELLA-CS, S.R.O, EndoChoice, Merit Endotek, Taewoong Medical, and Xlumena.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[healthcare768]

Endovascular Aneurysm Repair Market,by Product Type,By Indication,By End User,and By Geography-Global Industry Insights,Trends,Outlook,and Opportunity Analysis, 2017-2025

Aortic aneurysm is a medical condition, in which aorta, gets enlarged. Abdominal and Thoracic are two categories of aortic aneurysm. These conditions can lead to abdominal pain, low blood pressure, loss of consciousness or even death. Endovascular aneurysm repair (EVAR) is a minimally invasive surgical method to treat abdominal and thoracic aortic aneurysm. It is an alternative to open surgery for abdominal aortic aneurysm (AAA), which makes it relatively safe and less time consuming. However, not all patients suffering from aneurysm are suitable for EVAR. Also, it is difficult to treat aneurysm near or on the kidney using EVAR.

Increasing demand for minimally invasive surgeries to treat various medical conditions to boost growth of endovascular aneurysm repair (EVAR) market

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1339 According to a study published in the New England Journal of Medicine, 2016, the number of patients opting for endovascular aneurysm repair has increased significantly during 2005–2012. For instance, in 2005, the percentage of patients in the U.S. suffering from aneurysm opting for EVAR was around 50%, which increased to 75.4% in 2012. A similar pattern was observed in England. Increasing consumer inclination towards this revolutionary procedure is attributed to it being a minimally-invasive method of treatment that requires minimal stay in hospitals, smaller incisions, less scaring, and aids in rapid recovery. This is expected to aid in growth of the market.

Endovascular Aneurysm Repair (EVAR) Market Taxonomy

By Product Type Fenestrated Stent Graft Adjunctive Stent Graft Branched Stent Graft Others By Indication Abdominal Aortic Aneurysm (AAA) Thoracic Aortic aneurysm (TAA) Descending Aortic Aneurysm Ascending Aortic Aneurysm By End Users Hospitals Ambulatory care services Specialty clinics By Geography North America Europe Asia Pacific Latin America Middle East Africa North America is expected to hold a dominant position in global endovascular aneurysm repair (EVAR) market over the forecast period

North America accounted for the largest share in the global endovascular aneurysm market in 2016, owing to increasing prevalence of aneurysms and rising geriatric population, which is more prone to this condition. According to the New England Journal of Medicine, 2016, 278,921 patients underwent repair of abdominal aortic aneurysm in the U.S. during 2005–2012. According to Centers for Disease Control and Prevention (CDC), in 2014, aortic aneurysms led to death of 9,863 in the U.S. Moreover, aneurysm is more prevalent is geriatric population i.e. 50 years and above. According to the U.S. Population Reference Bureau, the population aged 65 years and above is expected to increase from 46 million in 2014 to over 98 million by 2060. With increasing geriatric population, prevalence of aneurysm is also expected to increase.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1339

Key players operating in endovascular aneurysm market include Medtronic plc. Cook Medical, Gore Medical, B. Braun Melsungen AG, Terumo Corporation, Boston Scientific Corporation, Abbott Laboratories, Volcano Corporation, C.R. Bard, Spectranetics International BV, Cordis Corporation (Johnson and Johnson Co.), and St. Jude Medical Inc.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[healthcare768]

Lab Automation Market,by Product Type,By Application,By End User and by Region-Global Trends,and Forecast to 2025

Lab Automation is a multi-disciplinary approach to develop and optimize on technologies in the laboratory, in order to improve the medical tests and processes. It has replaced the manual steps with automated processes, which were potentially dangerous and error-prone.

The global lab automation market is estimated to account for US$ 4,477.0 Mn in terms of value in 2020 and is expected to reach US$ 6,262.3 Mn by the end of 2027.

Global Lab Automation Market: Drivers

Increasing demand for lab automation in the pharmaceutical and biotechnology sector is expected to propel growth of the global lab automation market over the forecast period. Lab automation utilizes high end automated equipment such as automated liquid handling system, microplate reader, and automated storage and retrieval system. It also include software to perform variety of routine lab procedure such as sample analysis, assay performance, mixing of sample, storage of sample, and many other procedures. Lab automation allows improved productivity with less operational time and more accuracy by minimizing the human error in the operational tasks. Automated liquid handling system can perform three different procedures simultaneously such as sample preparation, reagent addition to different plates having samples, and movement of lab ware from periphery to front area of desk.

Moreover, increasing prevalence of chronic diseases is also expected to aid in growth of the market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1334

Global Lab Automation Market: Restraints

High cost of automation is expected to hinder growth of the global lab automation market. The high cost of automation is one of the objections that each laboratory faces. The higher investment resists the laboratories to buy the product. Moreover, the need to expand or remodel the laboratory’s workspace serves as a barrier in implementation of the lab automation, as it serves as an extra burden on the costing.

Market Trends/Key Takeaways

Increasing number of clinical trials is expected to propel growth of the global lab automation market. For instance, according to the U.S. National Library of Medicine, the number of clinical trials conducted in the U.S. increased from 30,978 in 2018 to 32,523 in 2019.

Global Lab Automation Market: Competitive Landscape

Major players operating in the global lab automation market include, Tecan Group Ltd., PerkinElmer Inc., Danaher Corporation, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Hamilton Company, COPAN Diagnostics, Inc., Abbot Diagnostics, Eppendorf, Roche Diagnostics, Siemens Healthineers, UiPath, and Porvair Sciences.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1334

Global Lab Automation Market: Key Developments

Major players in the market are focused on launching new products to expand their product portfolio For instance, in July 2020, Porvair Sciences, a manufacturer of microplates & microplate instruments, launched a new range of low-profile deep well microplates - optimized for laboratory automation.

Major players in the market are also focused on adopting collaboration strategies to expand their product portfolio. For instance, in April 2020, Hamilton Company and Integrated Micro-Chromatography Systems launched the affinityPure STAR assay ready workstation as part of their ongoing collaboration.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[healthcare768]

Disposable IV Therapy Products Market, by Product Type,by End User and by Region-Global Trends,and Forecast till 2025

Disposable IV Therapy Products Market – Drug Administration DevicesIntravenous (IV) therapy products are essential for most of the medical procedure. These supplies allow the convenient and safe administration of various nutrients and medications directly into a patient’s bloodstream. IV therapy products are easy to use and typically require one needle prick. This improves comfort and overall experience of patients. Therapies commonly used include nutrients, pain medicines, chemotherapy drugs, and antibiotics. The major advantage offered by disposable IV therapy product is precise delivery of drug dosage in a well-controlled manner throughout the body.Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1327Increasing number of patients suffering from chronic diseases area expected to augment market growthIncreasing number of chronic diseases demanding for disposable IV therapy products is expected to be a major factor driving growth of the global disposable IV therapy products market over the forecast period. According to a Centers for Disease Control and Prevention (CDC), in 2014, chronic diseases were the major cause of deaths. Cancer and heart disease together accounted for around 46% of all deaths. Diabetes is the major cause of kidney failure, lower-limb amputations, and new cases of impaired vision among adults. Moreover, health risk by dearth of exercise, high alcohol and tobacco consumption, poor nutrition cause much of the illness and early death due to chronic diseases. For instance, as per CDC statistics, an estimated 36.5 million adults in the U.S. smoked cigarettes in 2015. Cigarette smoking register for over 480,000 deaths every year. Furthermore, around 1 in 3 adults suffer from at least one type of cardiovascular disease and around 90% of the U.S. population aged 2 years or more consume high sodium, which can spur risk of high blood pressure.Technological advancements in IV therapy products to accelerate the market growthGrowing focus on cost containment and cost effectiveness at health care facilities coupled with technological advances in IV therapy products have allowed the effective and safe use of IV therapies. Increasing inclination of patients towards safety-enhancing pumping instruments and needleless technologies are expected to drive growth of the disposable IV therapy products market over the forecast period. For instance, in 2014 CareFusion (a Becton Dickinson subsidiary) launched MaxZero needleless connector (zero reflux connector) that offers the same technology as the MaxPlus connector, designed to reduce the risk of occlusions and infections. However, product recalls, reported errors, and lack of trained professionals are some factors expected to impede disposable IV therapy products market over the forecast period. For instance, infusion pump fails to make an audible alarm for a serious issue like an occlusion or the presence of air in the infusion tube.Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1327ajor players operating the global disposable IV therapy products market include B. Braun Melsungen AG, Baxter, Becton Dickinson & Company, Caesarea Medical Electronics, ICU Medical, Inc., JMS Co. Ltd., Lily Medical Corporation, Smiths Medical, and Terumo Corporation.About Coherent Market InsightsCoherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.Contact UsMr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[healthcare768]

Global Surgical Staplers Market, by Product,by Usage,by Application,by End User and by Geography-Trends and Forecast to 2025

Surgical stapling devices can be defined as the staplers which are used in surgical procedures in order to seal or close the wound or the incised portion of the body. These are specialized instruments that can be used to seal or close the both internal as well as external wounds.

Statistics:

The global surgical stapling devices market is estimated to account for US$ 4,364.6 Mn in terms of value by the end of 2027.

Global Surgical Stapling Devices Market: Drivers

Increasing prevalence of obesity is expected to propel growth of the global surgical stapling devices market over the forecast period. For instance, according to the Centers of Disease Control and Prevention, Behavioral Risk Factor Surveillance System, 2018, 71424.3 thousand people in the U.S. suffer from obesity.

Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.

Statistics:

North America held dominant position in the global surgical stapling devices market in 2019, accounting for 28.6% share in terms of value, followed by Europe and Asia Pacific, respectively.

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1318

Global Surgical Stapling Devices Market: Restraints

Use of surgical stapling devices can lead to injury after removing stapler, which is expected to hinder the market growth. For instance, in March 2019, the U.S. Food and Drug Administration received more than 41,000 adverse event reports — including 366 deaths — associated with surgical staplers and staples for internal use, and that it may require stricter product review of the devices.

Global Surgical Stapling Devices Market: Opportunities

R&D in functionality of devices is expected to offer lucrative growth opportunities for players in the global surgical stapling devices market. For instance, in January 2019, a Ethicon funded research stated that Ethicon’s Echelon Flex GST system had a 20% staple-line air leak rate when tested out on pig lungs under modeled physiologic breathing conditions, versus a 44% rate for Medtronic’s Endo Gia with Tri-Staple technology.

Moreover, development of reusable stapling devices is expected to aid in growth of the market.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1318

Market Trends/Key Takeaways

Misuse of surgical staplers is on the rise. For instance, according to 13th edition of ECRI Institute’s Top 10 Health Technology Hazards, published in October 2019, surgical stapler misuse is the top health technology hazard, beating out the likes of point-of-care ultrasounds and sterile processing errors.

Increasing concerns regarding injuries from surgical staplers has prompted several regulatory bodies to propose regulatory changes. For instance, in June 2019, The U.S. Food and Drug Administration’s General and Plastic Surgery Devices Panel recommended that surgical staplers for internal use be reclassified to a more highly regulated status.

Global Surgical Stapling Devices Market: Competitive Landscape

Major players operating in the global surgical stapling devices market include, Medtronic plc, Johnson & Johnson, 3M Company, Aesculap, Inc. (B. Braun), SeCQure Surgical Corporation, Purple Surgical Holdings Limited, Meril Life Sciences Pvt. Ltd., and Grena Ltd.

Global Surgical Stapling Devices Market: Key Developments

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in June 2020, Aesculap, Inc. launched SQ.line surgical instruments portfolio for spine and orthopedic procedures.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[healthcare768]

Breast Implants Market, by Implant Type, by Shape,by Application,by End user,and by Region-Global Trends, and Forecast till 2025

Breast implants are medical devices that are used to augment the size of the breasts, either for cosmetic applications or reconstruction purpose. Round breast implants are the most commonly used breast implants. Round breast implants have a tendency to appear fuller and there is less concern about rotating them in place as they are same shape all over.

Global Breast Implants Market: Drivers

Increasing prevalence of breast cancer is expected to propel growth of the global breast implants market over the forecast period. For instance, according to Breastcancer.org, in 2019, an estimated 268,600 new cases of invasive breast cancer were expected to be diagnosed in women in the U.S. along with 62,930 new cases of non-invasive (in situ) breast cancer.

Moreover, increasing adoption of highly cohesive silicone breast implants is also expected to aid in growth of the market. Silicone breast implants have high strength silicone gel that is textured with silicone shell. Such implants are thicker and contain more cohesive silicone gel, which eliminates the probability of filler leakage into the body.

Statistics:

North America held dominant position in the global breast implants market in 2019, accounting for 35.9% share in terms of value, followed by Latin America and Europe, respectively.

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1309

Global Breast Implants Market: Restraints

High cost of breast augmentation is expected to hamper growth of the market. For instance, in India, the total cost of breast augmentation (including cost of implants and cost of surgery) is around US$ 2,800.

Moreover, high risk of developing serious complications is also expected to limit the market growth. Breast implants are not lifetime devices and undergoing breast implant surgery may involves the risk of complications ultimately leading to breast implants removal at some point. Commonly observed complications include, tightening of the area around the implant (capsular contracture), additional surgeries, and implant removal.

Market Trends/Key Takeaways

The market in Asia Pacific is driven by increasing prevalence of breast cancer. For instance, according to the Union Health Ministry, Government of India, 2018 data, the prevalence of breast cancer is 25.8 per 100,000 women and the mortality rate for the disease is 12.7 per 100,000 women. Moreover, around 17, 97,900 women in India may suffer from breast cancer by 2020.

Major players in the market are focused on approval and launch of products to expand their product portfolio. For instance, in November 2018, Polytech Health & Aesthetics GmbH received the CE Mark for Polytech and B-Lite breast implants for another five years.

Regulations

U.S.

The required post-approval studies for silicone gel-filled breast implants are as follows:

Core Post-Approval Studies (Core Studies) – To assess long-term clinical performance of breast implants in women that enrolled in studies to support premarket approval applications. Large Post-Approval Studies (Large Studies) – To assess long-term outcomes and identify rare adverse events by enrolling more than 40,000 silicone gel-filled breast implant patients and following them for 10-years. Device Failure Studies (Failure Studies) – To further characterize the modes and causes of failure of explanted devices over a 10-year period. Focus Group Studies – To improve the format and content of the patient labeling. Annual Physician Informed Decision Survey (Informed Decision Study) – To monitor the process of how patient labeling is distributed to women considering silicone gel-filled breast implants. Global Breast Implants Market: Competitive Landscape

Major players operating in the global breast implants market include, Allergen, Inc., Mentor Worldwide LLC, GC Aesthetics Plc, Sientra, Inc., POLYTECH Health and Aesthetics GmBH, Establishment Labs S.A., LABORATORIES ARION, HANSBIOMED Co. Ltd., Groupe Sebbin SAS, GG Biotechnology Ltd, CollPlant Holdings Ltd., Cereplas, and PS Technology Development Limited.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1309

Global Breast Implants Market: Key Developments

Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in November 2019, Sientra, Inc., a medical aesthetics company, acquired FDA-approved silicone breast implant manufacturing operation from Lubrizol Life Science.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[healthcare768]

Respiratory Devices Market, by Product Type,by Age Group,by Application,by End User and by Region-Global Trends and forecast till 2025

Respiratory Devices Market – Insights Respiratory devices are medical devices that are used to assist a patient suffering from breathing problems. These devices are used in management and treatment of disorders such as fibrosis, asthma, chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome (ARDS).

Global Respiratory Devices Market: Drivers

High prevalence of COPD and obstructive sleep apnea is expected to propel growth of the global respiratory devices market over the forecast period. For instance, according to a report by Global Initiative for Chronic Obstruction Disease’s 2018 report, COPD is expected to result in 4.5 million global deaths annually by 2030. Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the World Health Organization, geriatric population is expected to reach 2 billion by 2050, up from 900 million in 2015. North America region held dominant position in the global respiratory devices market in 2018, accounting for 41.9% share in terms of value, followed by 2027.

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1299

Global Respiratory Devices Market: Restraints

Tempering in respiratory devices is expected to hinder growth of the market. For instance, in July 2019, researchers from CyberMDX reported identifying a susceptibility related to the GE Aestiva and GE Aespire devices, which could lead to unauthorized gas composition input, manipulation of barometric pressure settings and anesthetic agent type selection, remote silencing of alarms, and, alteration of date and time settings.

Global Respiratory Devices Market: Opportunities

R&D of multifunctional polymer composites is expected to offer lucrative growth opportunities for players in the global respiratory devices market. For instance, in February 2020, researchers from National Research Institute, Poland, reported development of a multifunctional polymer composite from polypropylene and poly (ethylene terephthalate) for filtering respiratory protective devices. Market Trends/Key Takeaways The market is witnessing development of portable devices for the treatment of ARDS. For instance, in August 2019, researchers from University of Michigan developed a portable device that analyzes a patient’s breath to provide quick and objective results that can help to manage ARDS. Market players are focused on offering multifunctional devices. For instance, Ventec Life Systems offers VOCSN, an integrated ventilator system that uses one machine to perform mechanical ventilation, oxygen delivery, cough assist, suction, and nebulization.

Regulations

U.S. Medical gases are drugs within the meaning of section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 321(g)(1)) and, pursuant to section 503(b)(1)(A) of the FD&C Act (21 U.S.C. 353(b)(1)(A)), are required to be dispensed by prescription. Medical gases are regulated as finished pharmaceuticals regardless of the stage of processing. Medical gases must be manufactured (e.g., processed, filled, transfilled, mixed, purified, separated, cascaded, transferred, packaged, and distributed) using CGMP, as set forth in 21 CFR Parts 210 and 211 and in conformance with current industry practice. The FD&C Act requires that a drug, including the finished dosage form and its components, meet CGMPs to assure drug safety, identity, strength, quality, and purity Firms manufacturing compressed medical gases are subject to issuance of Form 483 upon non-conformance with CGMP guidelines Common discrepancies noted in manufacturing and supply include Inadequate label control False or misleading label, label contains an inaccurate statement of the contents, or label contains inadequate directions for use (however, do not cite on FDA 483 as per IOM instructions 5.2.3.3 - Non-Reportable Observations) Inadequate cylinder prefill inspections and procedures, particularly failure to perform those intended to remove or detect residual gases or other contaminants in the cylinders

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1299

Global Respiratory Devices Market: Competitive Landscape

Major players operating in the global respiratory devices market include, Masimo Corporation, Teleflex Incorporated, Fisher & Paykel Healthcare Limited, ResMed. Inc., Hamilton Medical AG, Medtronic PLC, Koninklijke Philips N.V., Smiths Medical, General Electric Healthcare Limited, Drägerwerk AG & Co. KGaA, and Inogen Inc.

Global Respiratory Devices Market: Key Developments

Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in January 2020, Masimo Corporation signing of a definitive agreement to acquire the Connected Care assets from NantHealth, Inc.

Similarly, in November 2019, AdaptHealth Corp., a provider of CPAP and BiPAP machines and supplies and respiratory equipment, entered into a definitive agreement to acquire the Patient Care Solutions (PCS) business from McKesson Corporation.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[healthcare768]

Degenerative Disc Disease Treatment Market, By Treatment,and By End User- Global Industry Insights,Trends,Outlook,and Opportunity Analysis, 2017-2025

Degenerative Disc Disease Treatment Market – Insights Degenerative disc diseases are very frequent and debilitating disorders, and R&D activities surrounding this disease are highly cost intensive. Hence, many fund raising companies and manufacturers are engaged in raising funds for their research regarding the treatment of degenerative disc diseases.

Depending upon the level of pain, degenerative disc disease can be treated with two common processes which are non-surgical and spinal fusion. Non-surgical treatments include medications, physical therapy and chiropractic care. Whereas, spinal fusion is a procedure used to surgically treat degenerative disc disease.

The degenerative disc disease treatment market is expected to exhibit significant growth over the forecast period. This is owing to technological advancements such as artificial discs. For instance, in 2013, Zimmer Biomet launched Mobi-C, a two-level artificial disc for patients with issues at two consecutive spinal disc. Furthermore, manufacturers are focusing on acquisition strategies to strengthen their product portfolios which is expected to drive global degenerative disc disease treatment market growth. For instance, Centinel Spine in October 2017, entered into an asset purchase agreement to acquire the ProDisc Total Disc Replacement portfolio from DePuy Synthes.

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1280

An increasing launch of disc replacement surgical devices is expected to drive growth of the global degenerative disc disease treatment market

Various companies are focusing on launching innovative and technologically advanced products to meet the needs of customers, which is expected to propel the degenerative disc disease treatment market growth over the forecast period. For instance, in March 2019, Atlas Spine Inc. announced the launch of HiJak AC expandable cervical interbody fusion device. The product is expandable cervical interbody fusion device used for the spine fusion surgery. The device offers adjustment to both height and lordosis to easily restore lordosis and balance sagittal alignment of the spinal cord.

Global Degenerative Disc Disease Treatment Market - Restraints

Alternative therapies such as physiotherapy and special exercises are also used for treatment of degenerative disc disease, which is expected to hamper growth of the degenerative disc disease treatment market over the forecast period. For instance, according to data published in the Toronto Physiotherapy Journal in January 2014, physiotherapy is the most preferred first line treatment for degenerative disc disease among the aging population.

Global Degenerative Disc Disease Treatment Market - Regional Insights

On the basis of region, the global degenerative disc disease treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds a dominant position in the global degenerative disc disease treatment market owing to an increasing number of degenerative disc disease treatments. For instance, in September 2019, DePuy Synthes, a subsidiary of Johnson & Johnson Medical Devices Companies, launched CONDUIT Interbody Platform with EIT Cellular Titanium Technology. The product is designed to mimic natural bone structure and facilitate spinal fusion.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1280

Global Degenerative Disc Disease Treatment Market - Competitive Landscape

Key players operating in the global degenerative disc disease treatment market include Medtronic Plc., Globus Medical Inc., Johnson & Johnson, Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, RTI Surgical Holdings, Inc., Cousin Biotech, Ulrich Medical USA, Inc., Fresenius Kabi AG and Abbott Laboratories.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[healthcare768]

Medical Ceramics Market, by Material,Bio-active,by Application,and by Region-Global Trends,and Forecast till 2025

Medical Ceramics Market - Insights

Medical ceramics are products that are biocompatible and aid in repairing or replacing musculoskeletal hard connective tissues. The ceramic materials used for medical purposes is not the same as porcelain type ceramic materials. Medical ceramic is closely related to either the body's own materials or is extremely durable metal oxides that are primarily used in dental and orthopedic applications as implants or replacements. Ceramic material with high-purity, high-density, and fine-grained polycrystalline alumina is used for load-bearing hip prostheses. Furthermore, other bio-ceramic implants can serve as porous media to support the ingrowth of new bone tissue such as materials that bio-react with bone, or as scaffolds that are completely resorbed after establishing a template for tissue growth. Increasing prevalence of joint-related diseases and dental problems had led to development of new technologies and methods. For instance, in 2016, Glidewell Laboratories launched a new line of dental bone grafting products under the brand name Newport Biologics. This is expected to fuel adoption of medical ceramics over the forecast period.

The global medical ceramics market is estimated to be valued at US$ 3,835.7 million in 2017 and is expected to witness a CAGR of 6.1% over the forecast period (2017–2025).

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1261

Rise in surgical procedures related to orthopedic and dental implants is expected to augment the market growth

Rising number of medical procedures involving dental implants, orthopedic implants, and others is one of the major factors driving growth of this market. According to the European Commission, 2015, around 800,000 hip procedures were carried out every year in Europe, costing around US$ 1.5 billion. The market growth is also driven by development of novel product varieties with higher mechanical strengths and flexibility. Due to their excellent frictional properties, technical ceramics are gaining popularity in endo-prosthetics. Increasing trauma cases due to falls and road accidents, requires medical intervention (orthopedics), thus, augmenting the need for medical ceramics products. In 2012, according to the National Institute of Health, knee is the most commonly injured joint by adolescent athletes with an estimated 2.5 million sports-related injuries presenting to emergency departments, annually in the U.S. This number is expected to increase significantly over the forecast period.

Manufacturers are focusing on developing new ceramics to be used in various medical applications. For instance, in March 2017, CeramTec launched its newly developed dental ceramic, Zirconium Oxide Bright, at International Dental Show (IDS) in Cologne, Germany. The material combines high translucency and high strength and is suitable for all dental prostheses treatments.

North America market accounted for the largest market share, followed by Europe in 2016. This is owing to high usage of implantable medical devices, furthermore, rise in number of osteoporotic fractures in the U.S. and presence of relatively large number of medical device manufacturers in this region is expected to be a factor for growth of the medical ceramics market in this region. For instance, according to the National Osteoporosis Foundation (NOF), over 1.3 million osteoporotic fractures occur each year in the U.S. The market in Asia Pacific and Latin America is also expected to witness substantial growth.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1261 Some of the key players in medical ceramics market are CoorsTek Medical, H.C. Starck GmbH, Tosoh Corporation, Noritake Co., Ltd., 3M ESPE, Morgan Advanced Materials plc, Ceramtec, Pl Ceramic GmbH, Lithoz, and Kyocera Corporation.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[healthcare768]

Laboratory Centrifuge Equipment Market,by Design of Rotor,by Area of Application,by Configuration,by Temperature Variation Facility-Global Industry Insights,Trends,Outlook,and Opportunity Analysis,2017-2025

Laboratory centrifuge is an equipment used to separate different material from liquid medium based on their density, shape, size, and viscosity of liquid medium in which they are dissolved. Centrifuge equipment works on the principle of centrifugation, in which denser material settles at the bottom of a centrifuge tube. Centrifuge is used in various applications such as separation of cellular element such as RBC and WBC from blood sample, In hematology lab for Packed Cell Volume determination (Diagnostic Purpose majorly), removal of cellular component for microscopic study (Research Purpose), removal of protein precipitate from analytical sample, isolation of macromolecules such as DNA, RNA, and lipids from cell, and separation of solid or semisolid precipitant from analytical sample or two immiscible fluids from each other in suspension (Research Purpose). Increasing demand for multifunction, reliable and durable laboratory centrifuge equipment to conduct variety of laboratory work as mentioned above is driving growth of the laboratory centrifuge equipment market.

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1231

Increasing diagnostics and research and development activities to fuel the growth of laboratory centrifuge equipment market

According to the World Health Organization (WHO) fact sheet, in 2017, 70% of deaths worldwide were due to non-communicable disease (NCD) such as cardio-vascular disease, cancer, diabetes, which is influencing pharmaceutical companies to invest more in research and development of cost-effective therapies, ultimately increasing demand for essential lab equipment such as centrifuge. According to World Economic Forum 2015 statistics, pharmaceutical companies invest majorly on research and development (Astra Zeneca tops the list with investment of 25.5% of its total revenue of financial year 2014-15). Increasing health awareness among population is propelling the growth of diagnostic market for which laboratory centrifuge equipment is essential. North America region is leading the centrifuge equipment market. According to Organization for Economic Co-operation and Development (OECD) report, North America spends 2.5% more than rest of OECD countries on health in which diagnostics holds a major share. The recent past has witnessed a significant increase in number of clinical trials for generic products (Bioequivalence safety and efficacy) due to off patenting of novel drug molecules, which in turn is increasing the demand for centrifuge equipment.

Laboratory Centrifuge Equipment Market Taxonomy:

On the basis of rotor design:

Fixed Angle Rotor Horizontal Rotor Vertical Rotor On the basis of application area:

Diagnostics Research and Development On the basis configuration:

Bench Top Portable Micro centrifuge Ultracentrifuge On the basis of temperature variation facility:

Refrigerated Non-Refrigerated On the basis of speed of rotation:

Low High Ultra On the basis end user:

Diagnostic laboratories Pharmaceutical and Biotech companies Research and academic places Technological advancement and development of new medicinal approaches such as personalized medicine and pharmacogenomics are propelling growth of the laboratory centrifuge equipment market. This is owing to increasing adoption of gene testing and associated procedures that extensively requires efficient and high precision centrifuge equipment. The market has witnessed major technological advancements, with market players focusing on differentiating their products by integrating latest technologies. In November 2017, Beckmann Coulter launched Avanti J-15 series laboratory centrifuge equipment, which runs on harmonic technology that reduces time by 10% for centrifugation, improves operational efficiency, and performs different functions (Blood sample processing, nucleic acid purification, Cell Culturing, protein concentration, and assay) that otherwise requires different centrifuge equipment.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1231

Major players in the global laboratory centrifuge equipment market include Thermo Fisher Scientific, Eppendorf Corporation, Beckmann Coulter Inc., Hettich Lab Technology, Danaher Corporation, Hitachi Koki ltd., and Bio-Rad Laboratories.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]

[healthcare768]

Ventilators Market, by Product Type, by Technology,by Age Group,by Interface,by Mode,by End User and Geography—Global Industry Insights, Trends,Outlook,and Opportunity Analysis,2017–2025

A ventilator is a medical device used to support the breathing of patients. It is a form of breathing assistance in which an endotracheal tube is directed towards the airway of patient and it is connected to ventilator system. They are often used during surgery when patient is under anesthesia, which puts a patient to sleep without interrupting normal breathing. This system can be used as a diagnostic tool to measure static compliance of airway resistance and irregular functioning of respiratory system. The failure of ventilators may result in death so it is classed as life critical system and the system should be highly reliable.

Increase in number of private and public hospitals attributing to the growth of ventilators market

According to World Health Organization (WHO) fact sheet 2015, around 3 million people died due to of chronic obstructive pulmonary disease (COPD), accounting for 5% of all deaths. The rising incidences of chronic diseases such as chronic obstructive pulmonary diseases (COPD), bronchitis, asthma, and increase in number of accidental cases are some of the situations where medical ventilators are used. The rising incidence rate of preterm birth, respiratory diseases, growth in geriatric population associated disorders, growing pollution level, the changing lifestyle of people and habits such as smoking and drinking leading to enhanced risk of respiratory infections, lung diseases and cancer are driving the ventilators market. According to the World Health Organization (WHO), 2017, an estimated 15 million infants are born preterm annually accounting for approximately 1 million deaths in 2015. The survey also states that three-quarters of these deaths could be prevented with the current cost-effective interventions. However, the complications associated with the use of medical ventilator such as resistance from patients and physicians for technology transition, disorders such as barotrauma, lung injury, pneumonia and high cost of medical ventilators are some of the factors restraining the growth of the global ventilators market.

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1220

Global Ventilators Market Taxonomy:

The global ventilators market is segmented as per product type, age group, interface, mode, end user and region.

On the basis of product type, the global ventilators market is segmented into:

Portable Ventilators Stationary Ventilators On the basis of technology, the global ventilators market is segmented into:

Mechanical Ventilators Automatic Ventilators On the basis of age group, the global ventilators market is segmented into:

Adult/pediatric ventilators Neonatal/infant ventilators On the basis of interface, the global ventilators market is segmented into:

Invasive Ventilators Non-Invasive Ventilators On the basis of mode, the global ventilators market is segmented into:

Combined Mode Ventilation Volume Mode Ventilation Pressure Mode Ventilation Others On the basis of end user, the global ventilators market is segmented into:

Hospitals Ambulatory Care Centers Home Care Setting North America dominates the ventilators market due to increasing incidence of coronary diseases

Regional segmentation of the global ventilators market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia pacific, Middle East and Africa. North America dominates the ventilators market, followed by Europe. According to the American Heart Association, 2017, about 92.1 million American adults are suffering form of cardiovascular disease or the after-effects of stroke. According to the study conducted by Department of Anesthesiology, Columbia University, 2014, ICU occupancy ranged from 57.4% to 82.1% and the number of beds filled with mechanically ventilated patients ranged from 20.7% to 38.9% in the U.S., which is driving the growth of ventilators market in North America.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1220 Major players are launching technologically advanced product to hold the major share in ventilators market

Key players operating the global ventilators market include Becton, Philips Healthcare, ResMed Inc., Medtronic Plc, Dragers Group, Smiths Group Plc, Hamilton Medical, GE Healthcare, and Teleflex Incorporated. Market players are focused on launching new product to maintain lead in the ventilator market. For instance, the medical ventilator by Smiths Medical, PNEPAC Para PAC was the recent advancement approved by the U.S. FDA in 2014, which offers greater control of breathing parameters with MRI compatibility giving maximum flexibility for transport within the medical setting. The strategies such as merger and acquisition with local and international players and focus on technological advancements are adopted by manufacturers to sustain their position in the ventilators market.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: [phone] Email: [email protected]